Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01606280 · ClinicalTrials.gov registry record
Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation
A clinical trial of Amyloidosis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01606280 is a study of Amyloidosis that has completed, run by Mayo Clinic. The registered enrollment target is 400 participants, below the 1,115-participant average among 28 other Amyloidosis trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01606280, a study of Amyloidosis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the value of stem cell transplantation in managing light chain amyloidisis.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01606280
The ClinicalTrials.gov registry entry for NCT01606280 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,115-participant average among 28 other Amyloidosis trials with a reported enrollment target (64% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyloidosis appearing as the primary indexed condition, and to 0 interventions.
NCT01606280 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01606280 about?
NCT01606280 is a clinical study titled "Long-term Outcomes of Patients With Primary Amyloidosis After Stem Cell Transplantation". This study examines the value of stem cell transplantation in managing light chain amyloidisis.
What is the current status of trial NCT01606280?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2011-06. Estimated completion is 2013-06.
What conditions does trial NCT01606280 study?
This clinical trial studies the following conditions: Amyloidosis.
Who is sponsoring clinical trial NCT01606280?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01606280 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RECRUITING · Phase 2
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
RECRUITING
-
A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
RECRUITING
-
Dietary Reporting in the Amyloidoses
RECRUITING · NA
-
Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RECRUITING · Phase 1
-
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.